Alere awarded grant to develop technologies for TB detection Alere Inc.

Alere awarded grant to develop technologies for TB detection Alere Inc. announced today that it’s been awarded a grant as high as $21 .6 million and personal debt financing of up to $20.6 million from the Expenses & Melinda Gates Foundation. The $21.6 million grant shall fund the development of a tuberculosis assay, which will be designed for use in both resource-constrained and well-resourced configurations. In addition, the Gates Foundation provides below-market loans as high as $20.6 million for the expansion and scale up of Alere's manufacturing services in Jena, Germany for both the POC TB Nucleic Acid Test and the POC HIV Viral Load Check currently in the ultimate stages of advancement.

The accreditation is normally a voluntary review process for organizations that provide health information products . Governed by NCQA’s rigorous Specifications for Qualification, the accreditation procedure evaluates an HIP organization’s management of varied aspects of its data collection and systems procedure, and the process it uses to boost the services it offers continuously. Related StoriesGenetic carrier screening: an interview with Don Hardison, CEO of Great Begin GeneticsSurgical startup seeks financing to build virtual reality schooling libraryOJ Bio at Medica 2015 – Point of Treatment diagnostics' part in reducing antibiotics prescribing Healthcare companies consider NCQA Accreditation to be the gold standard for evaluating health care quality and value, says Alere Wellness CEO Tom Underwood.